City

Beijing (1)

Chengdu (1)

Los Alamitos (1)

Condition

Relapsed or Refractory Lymphomas (2)

Advanced Solid Tumor (1)

Locally Advanced /Metastatic Solid Tumors (1)

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Lantern Pharma Inc. (1)

Tayu Huaxia Biotech Medical Group Co., Ltd. (1)

Collaborator

Intervention

lp-284 (1)

ty101 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

relapsed or refractory lymphomas

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Relapsed or Refractory Lymphomas, Advanced Solid Tumor Trial in Los Alamitos (LP-284)

Not yet recruiting

Relapsed or Refractory Lymphomas
Advanced Solid Tumor

LP-284

Los Alamitos, California

Cancer and Blood Specialty Clinic

Nov 9, 2023

Locally Advanced /Metastatic Solid Tumors, Relapsed or Refractory Lymphomas Trial in Beijing, Chengdu (TY101)

Recruiting

Locally Advanced /Metastatic Solid Tumors
Relapsed or Refractory Lymphomas

TY101

Beijing, Beijing, China
+2 more

Aug 12, 2021